EXTON, Pa., May 5, 2021 /PRNewswire/ -- West
Pharmaceutical Services, Inc. (NYSE: WST), a global leader in
innovative solutions for injectable drug administration, announced
today that the Company's Board of Directors has approved a
third-quarter 2021 dividend of $0.17
per share. The dividend will be paid on August 4, 2021, to shareholders of record as of
July 21, 2021.
The Company also announced that management will present an
overview of the business for investors at the upcoming Bank of
America Securities 2021 Healthcare Conference taking place
virtually on Tuesday, May 11, 2021 at
2:45 p.m. EDT.
A live audio webcast of the presentation and a copy of the
presentation materials will be accessible from the Company's
website at www.westpharma.com/en/investors.
About West
West Pharmaceutical Services, Inc. is a leading provider of
innovative, high-quality injectable solutions and services. As a
trusted partner to established and emerging drug developers, West
helps ensure the safe, effective containment and delivery of
life-saving and life-enhancing medicines for patients. With almost
10,000 team members across 50 sites worldwide, West helps support
our customers by delivering over 40 billion components and devices
each year.
Headquartered in Exton, Pennsylvania, and in business for nearly a
century, West in its fiscal year 2020 generated over $2.15
billion in sales. West is traded on the New York Stock
Exchange (NYSE: WST) and is included on the Standard
& Poor's 500 index. For more information,
visit https://www.westpharma.com/.
All trademarks and registered trademarks used in this release
are the property of West Pharmaceutical Services, Inc. or its
subsidiaries, in the United States
and other jurisdictions, unless otherwise noted.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/west-announces-third-quarter-dividend-and-participation-in-upcoming-investor-conference-301283940.html
SOURCE West Pharmaceutical Services, Inc.